Helius Medical Technologies, Inc.
Index- P/E- EPS (ttm)-7.05 Insider Own1.10% Shs Outstand3.78M Perf Week6.12%
Market Cap2.04M Forward P/E- EPS next Y-2.25 Insider Trans0.00% Shs Float3.36M Perf Month-50.07%
Income-19.10M PEG- EPS next Q-1.12 Inst Own28.30% Short Float5.16% Perf Quarter-66.61%
Sales0.60M P/S3.40 EPS this Y70.50% Inst Trans16.99% Short Ratio0.06 Perf Half Y-86.85%
Book/sh3.59 P/B0.15 EPS next Y46.20% ROA-139.90% Target Price25.00 Perf Year-96.44%
Cash/sh2.88 P/C0.19 EPS next 5Y- ROE-181.20% 52W Range0.45 - 15.68 Perf YTD-89.71%
Dividend- P/FCF- EPS past 5Y15.50% ROI-615.30% 52W High-96.59% Beta0.71
Dividend %- Quick Ratio4.60 Sales past 5Y- Gross Margin35.40% 52W Low18.47% ATR0.25
Employees19 Current Ratio4.70 Sales Q/Q50.00% Oper. Margin- RSI (14)39.51 Volatility11.21% 18.23%
OptionableNo Debt/Eq0.00 EPS Q/Q26.00% Profit Margin- Rel Volume2.43 Prev Close0.55
ShortableYes LT Debt/Eq0.00 EarningsAug 15 AMC Payout- Avg Volume2.89M Price0.53
Recom1.00 SMA20-38.46% SMA50-57.67% SMA200-86.32% Volume7,028,452 Change-2.85%
Mar-24-21Initiated Noble Capital Markets Outperform $20
Aug-15-22 04:05PM  
Aug-10-22 07:05AM  
Aug-05-22 08:38AM  
Jul-15-22 10:55AM  
Jul-12-22 07:05AM  
Jun-17-22 12:00PM  
Jun-06-22 07:05AM  
Jun-01-22 07:05AM  
May-31-22 08:36AM  
May-24-22 04:05PM  
May-17-22 07:30AM  
May-12-22 06:50AM  
May-03-22 07:05AM  
Apr-27-22 07:05AM  
Apr-26-22 07:05AM  
Mar-14-22 04:05PM  
Feb-17-22 05:20PM  
Jan-26-22 04:30PM  
Dec-20-21 05:00PM  
Dec-17-21 07:05AM  
Dec-14-21 07:05AM  
Dec-06-21 07:05AM  
Nov-15-21 11:49AM  
Nov-12-21 04:05PM  
Nov-10-21 04:05PM  
Nov-09-21 04:30PM  
Nov-08-21 07:05AM  
Nov-04-21 06:55AM  
Nov-03-21 03:01PM  
Nov-01-21 07:05AM  
Oct-29-21 04:30PM  
Oct-12-21 07:05AM  
Sep-22-21 04:05PM  
Sep-14-21 07:05AM  
Sep-07-21 07:05AM  
Aug-25-21 07:00AM  
Aug-18-21 09:28AM  
Aug-17-21 08:28AM  
Aug-12-21 07:15PM  
Aug-11-21 05:00PM  
Aug-05-21 03:01PM  
Jul-12-21 04:05PM  
Jul-08-21 07:30AM  
Jul-07-21 05:30PM  
Jun-30-21 07:30AM  
Jun-15-21 08:30AM  
Jun-08-21 04:05PM  
Jun-02-21 07:05AM  
May-17-21 04:05PM  
Apr-19-21 09:00AM  
Apr-15-21 08:35AM  
Apr-07-21 04:30PM  
Mar-29-21 06:30AM  
Mar-17-21 04:05PM  
Mar-10-21 04:05PM  
Feb-22-21 12:45AM  
Feb-02-21 07:30AM  
Feb-01-21 05:15PM  
Jan-28-21 08:41AM  
Jan-20-21 07:05AM  
Jan-19-21 07:05AM  
Jan-15-21 12:37PM  
Jan-13-21 07:00AM  
Jan-11-21 07:05AM  
Jan-05-21 04:05PM  
Jan-04-21 07:05AM  
Dec-31-20 07:05AM  
Nov-19-20 06:45AM  
Nov-12-20 04:05PM  
Nov-05-20 07:05AM  
Nov-04-20 07:05AM  
Nov-02-20 05:00PM  
Oct-26-20 05:45PM  
Oct-21-20 04:32PM  
Oct-19-20 05:17PM  
Oct-14-20 07:05AM  
Oct-08-20 07:30AM  
Sep-08-20 07:05AM  
Sep-02-20 06:21PM  
Aug-31-20 02:00PM  
Aug-25-20 07:05AM  
Aug-12-20 06:05PM  
Aug-10-20 07:05AM  
Aug-06-20 12:30PM  
Aug-05-20 03:34PM  
Jul-14-20 07:05AM  
Jun-15-20 07:00AM  
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANDREEFF DANEPresident and CEODec 17Buy5.255,10026,78953,779Dec 21 08:15 AM
MATHIESEN JEFFREY SCFO and TreasurerDec 17Buy5.313,00015,9293,937Dec 20 08:15 AM
ANDREEFF DANEPresident and CEONov 12Buy8.0037,500300,00086,482Nov 15 08:00 AM
ANDREEFF DANEPresident and CEOSep 15Buy14.7210,000147,22263,522Sep 16 04:05 PM
ANDREEFF DANEPresident and CEOSep 10Buy14.9610,000149,62958,114Sep 13 04:05 PM
ANDREEFF DANEPresident and CEOSep 08Buy14.836,00088,95752,706Sep 09 04:06 PM
ANDREEFF DANEPresident and CEOSep 07Buy14.864,45066,13949,461Sep 09 04:06 PM